These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 18160573)

  • 1. Further removal of factor v related antigen from bovine thrombin by utilizing a membrane-filtration step.
    Terrab A; Pawlak D; Spaay P; Hoppensteadt D; Fareed J
    Clin Appl Thromb Hemost; 2008 Apr; 14(2):135-40. PubMed ID: 18160573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced immunogenic potential of membrane filtered bovine thrombin preparations for hemostatic application.
    Zhu H; Hoppensteadt D; Wahi R; Cunanan J; Adiguzel C; Bick RL; Fareed J
    Clin Appl Thromb Hemost; 2009 Feb; 15(1):32-40. PubMed ID: 18977777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of immunogenic potentials of bovine thrombin preparations.
    Zhu H; Hoppensteadt D; Adiguzel C; Bick RL; Fareed J
    Clin Appl Thromb Hemost; 2009 Feb; 15(1):41-9. PubMed ID: 19117966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-reactivity of rabbit anti-bovine prothrombin/thrombin IgGs with bovine factor V/Va-related antigens.
    He Zhu ; Hoppensteadt D; Morris M; Fareed J
    Clin Appl Thromb Hemost; 2010 Oct; 16(5):522-8. PubMed ID: 20699260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunization by bovine thrombin used with fibrin glue during cardiovascular operations. Development of thrombin and factor V inhibitors.
    Berruyer M; Amiral J; Ffrench P; Belleville J; Bastien O; Clerc J; Kassir A; Estanove S; Dechavanne M
    J Thorac Cardiovasc Surg; 1993 May; 105(5):892-7. PubMed ID: 8487567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative purity of thrombin-based hemostatic agents used in surgery.
    Schoenecker JG; Johnson RK; Fields RC; Lesher AP; Domzalski T; Baig K; Lawson JH; Parker W
    J Am Coll Surg; 2003 Oct; 197(4):580-90. PubMed ID: 14522327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative purity of different bovine thrombin preparations.
    Zhu H; Hoppensteadt D; Iqbal O; Litinas E; Adiguzel C; Fareed J
    Clin Appl Thromb Hemost; 2009 Dec; 15(6):681-8. PubMed ID: 19850589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase 3, randomized, double-blind study of plasma-derived human thrombin versus bovine thrombin in achieving hemostasis in patients undergoing surgery.
    Doria C; Fischer CP; Wood CG; Li PM; Marra S; Hart J
    Curr Med Res Opin; 2008 Mar; 24(3):785-94. PubMed ID: 18241525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicenter pilot study to estimate the prevalence of bovine and human coagulation antibodies in the general US population.
    Fareed J; Paterson CA; Crean SM
    Clin Appl Thromb Hemost; 2011 Apr; 17(2):164-70. PubMed ID: 21078614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk and clinical significance of developing antibodies induced by topical thrombin preparations.
    Dorion RP; Hamati HF; Landis B; Frey C; Heydt D; Carey D
    Arch Pathol Lab Med; 1998 Oct; 122(10):887-94. PubMed ID: 9786349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquired coagulation factor inhibitors in children after topical bovine thrombin exposure.
    Savage WJ; Kickler TS; Takemoto CM
    Pediatr Blood Cancer; 2007 Dec; 49(7):1025-9. PubMed ID: 16526049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical use and immunologic impact of thrombin in surgery.
    Lawson JH
    Semin Thromb Hemost; 2006 Apr; 32 Suppl 1():98-110. PubMed ID: 16673271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of antibodies to thrombin and factor V with recurrent bleeding in a patient exposed to topical bovine thrombin.
    Zehnder JL; Leung LL
    Blood; 1990 Nov; 76(10):2011-6. PubMed ID: 2242423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serological analysis of patients treated with a new surgical hemostat containing bovine proteins and autologous plasma.
    Nelson PA; Powers JN; Estridge TD; Elder EA; Alea AD; Sidhu PK; Sehl LC; DeLustro FA
    J Biomed Mater Res; 2001; 58(6):710-9. PubMed ID: 11745525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the esterase (TAMe) and clotting activities of human and bovine thrombin preparations.
    Lanchantin GF; Presant CA; Hart DW; Friedmann JA
    Thromb Diath Haemorrh; 1965 Sep; 14(1-2):159-75. PubMed ID: 16955973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antihuman factor V antibodies after use of relatively pure bovine thrombin.
    Lawson JH; Lynn KA; Vanmatre RM; Domzalski T; Klemp KF; Ortel TL; Niklason LE; Parker W
    Ann Thorac Surg; 2005 Mar; 79(3):1037-8. PubMed ID: 15734434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multimerin 1 binds factor V and activated factor V with high affinity and inhibits thrombin generation.
    Jeimy SB; Fuller N; Tasneem S; Segers K; Stafford AR; Weitz JI; Camire RM; Nicolaes GA; Hayward CP
    Thromb Haemost; 2008 Dec; 100(6):1058-67. PubMed ID: 19132231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune-mediated coagulopathy: a case report.
    Naoum JJ
    Pharmacotherapy; 2009 Jul; 29(7 Pt 2):13S-7S. PubMed ID: 19558280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An advantageous method utilizing new homogenizing device BioMasher and a sensitive ELISA to detect bovine spongiform encephalopathy accurately in brain tissue.
    Yamamoto T; Ushiki Y; Hara S; Hall WW; Tsukagoshi-Nagai H; Yokoyama T; Tagawa Y; Sata T; Yamakawa Y; Kinoshita N; Tamura F; Hattori S; Irie S
    J Virol Methods; 2008 May; 149(2):316-25. PubMed ID: 18346796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of immunoassay and real-time PCR methods for the detection of Jembrana disease virus infection in Bali cattle.
    Lewis J; McNab T; Tenaya M; Hartaningsih N; Wilcox G; Desport M
    J Virol Methods; 2009 Jul; 159(1):81-6. PubMed ID: 19442849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.